Vanderbilt Health and Eli Lilly are developing an AI agent to speed Alzheimer's disease treatment, with plans for radiology-focused AI tools.
Key Details
- 1Vanderbilt Health received a $600,000 grant from Eli Lilly to build an AI triage agent for Alzheimer's care in the EHR system.
- 2The AI tool will streamline referrals, summarize charts, flag missing details, and prioritize cases, aiming to reduce wait times for monoclonal antibody treatment.
- 3The project will be piloted with data from over 5,300 patients at Vanderbilt Health, targeting reduced time from diagnosis to infusion.
- 4Plans include a second AI agent to analyze MRI images and generate Alzheimer's safety reports for radiologists, and a third to support insurance authorization.
- 5Outcomes will be measured by reduced delays across the dementia care pathway.
Why It Matters
The integration of AI triage and radiology-focused agents aims to address bottlenecks in Alzheimer's care, supporting faster and more accurate treatment. Success here could set a model for scalable, AI-enhanced workflows across radiology and neurology.
Source
EurekAlert
Related News
•EurekAlert
AI Framework Adapts Smartphone Audio for Pediatric Lung Sound Screening
Researchers developed a domain-adaptive deep learning model enabling smartphones to detect abnormal lung sounds in children for remote screening.
•EurekAlert
HKU Launches Centre for Health AI Research and Translation
The University of Hong Kong has established the Centre for Health AI Research and Translation (CHART) to drive trustworthy, patient-centered AI innovation in healthcare.
•EurekAlert
Holographic Neural Network Achieves Multi-Task AI via Light-Based Computing
Researchers have developed a holographic neural network using optics to perform multiple AI classification tasks simultaneously without hardware reconfiguration.